Drawing for ABSOLUTE ELEMENTS

USPTO serial 76325767

ABSOLUTE ELEMENTS

Reviewed by CopyMark Law Group

Reg. 2710051Status 710
Filing date
Status date
Registration date
Apr 22, 2003
Examiner
COWARD, JEFFERY
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ABSOLUTE ELEMENTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Caroline C. Smith

CAROLINE C SMITH SHAW PITTMAN LLP2300 N ST NWWASHINGTON, DC 20037-1128UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003NON-MEDICATED LIP BALM; PETROLEUM JELLY FOR COSMETIC PURPOSES; ALL PURPOSE COTTON SWABS FOR PERSONAL USE; HAIR SHAMPOO; HAIR CONDITIONERS; HAIR GEL; AFTER SHAVE LOTIONS; NAIL POLISH REMOVER; COTTON BALLS FOR COSMETIC PURPOSES; COSMETIC BALLS; COSMETIC PADS; SKIN LOTION; SKIN CREAM; HERBAL BODY WASH; BATH POWDER; FACIAL CREAMS AND LOTIONS AND FACIAL CLEANSING STRIPSSECTION 8 - CANCELLEDApr 1, 2002
005PETROLEUM JELLY FOR MEDICAL PURPOSES; VITAMIN A AND D OINTMENT; RUBBING ALCOHOL; HYDROGEN PEROXIDE FOR MEDICAL USE; WITCH HAZEL; EPSOM SALTS; DANDRUFF SHAMPOO; DANDRUFF SHAMPOO INCORPORATING CONDITIONER; HYDROCORTISONE CREAM; ANTI-ITCH LOTION AND CREAM; TOPICAL ANALGESIC PREPARATIONS; MEDICATED SKIN CREAM; MEDICATED BODY POWDER; ACNE MEDICATIONS; ACNE TREATMENT PREPARATIONS; CONTACT LENS CLEANING SOLUTIONS; EYE DROPS AND TOPICAL FUNGICIDE FOR PERSONAL USE; ANTIBACTERIAL ALCOHOL SKIN SANITIZER GEL; ANTISEPTIC SKIN CLEANSERSECTION 8 - CANCELLEDApr 1, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 28, 2009C8..CANCELLED SEC. 8 (6-YR)—
May 29, 2008CFITCASE FILE IN TICRS—
Apr 22, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 17, 2003CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 17, 2003DOCKASSIGNED TO EXAMINER—
Jan 16, 2003SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 8, 2002IUAFUSE AMENDMENT FILED—
Nov 8, 2002MAILPAPER RECEIVED—
Sep 10, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 18, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 29, 2002NPUBNOTICE OF PUBLICATION—
Jan 25, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2002CNEAEXAMINER'S AMENDMENT MAILED—
Jan 15, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance